Results 151 to 160 of about 30,070 (260)
ABSTRACT Tacrolimus pharmacokinetics shows wide interindividual variability after allogeneic hematopoietic cell transplantation (HCT), potentially influencing both effectiveness and toxicity. The concentration‐to‐dose (C/D) ratio has been proposed as a simple surrogate marker of tacrolimus metabolism, enabling patient stratification into fast or slow ...
Luiz Carlos da Costa‐Junior +8 more
wiley +1 more source
Sotatercept for the Treatment of Myeloproliferative Neoplasm-Associated Group 5 Pulmonary Hypertension. [PDF]
Ali HR +9 more
europepmc +1 more source
Myelodysplastic/myeloproliferative diseases of childhood cause a relevant disease burden, and many of these diseases may have a fatal course. The use of next-generation sequencing (NGS) has led to the identification of novel genetic variants in patients ...
Kapp, F. +19 more
core +1 more source
A Comprehensive Echocardiographic Assessment of Patients With Chronic Myeloid Leukemia on Dasatinib
In a retrospective cohort of 199 adult patients with CML on Dasatinib in a single quaternary center, approximately 25% patients had routine baseline and follow‐up echocardiogram. Dasatinib was associated with significant changes in structural and diastolic parameters.
Chen Chen +4 more
wiley +1 more source
Low-dose methotrexate in myeloproliferative neoplasm models
Kavitha Chinnaiya +10 more
doaj +1 more source
Myelodysplastic/Myeloproliferative Neoplasm in a Dog: A Case Report. [PDF]
Cha S, Yu D, Bae H.
europepmc +1 more source
ABSTRACT Background Individuals with polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF) face transformation risks to acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). While older age is linked to increased risk, it remains unclear whether risk increases with age or with disease duration.
Nurgul Batyrbekova +5 more
wiley +1 more source
A Case of Myeloproliferative Neoplasm-Associated Glomerulopathy in a Patient With Myelofibrosis. [PDF]
Leibowitz S +4 more
europepmc +1 more source
IRF4 dysregulation in chronic myelomonocytic leukemia: another brick in the wall of myelodysplastic/myeloproliferative ...
Cosimo Cumbo +17 more
core +1 more source
ABSTRACT Background Vascular liver diseases (VLDs) predominantly affect young adults and require lifelong monitoring. The health‐related quality of life (HRQoL) of patients with VLDs is deteriorated, with high levels of fatigue and depressive symptoms, but their lived experience and unmet needs remain unknown.
Anouck Alary +17 more
wiley +1 more source

